Company · positioning

GenentechIncumbent

Positioned in 3 collision spaces.

3Collision spaces

Biobank-driven target discovery plus advanced therapeutic delivery platforms.

Deep neurodegeneration/amyloid programs plus biologics delivery R&D.

Deep tumor-microenvironment and computational biology programs targeting matrix-driven metastasis.